Study to Assess Adverse Events and Change in Disease Activity in Adult Participants With Select Advanced Solid Tumor Indications Receiving Intravenous (IV) ABBV-400
Applying to START-San Antonio · San Antonio, Texas
Answer a few short questions to share with the research team.